Use of Statistics to Assess Serious Adverse Events in Clinical Trials of New Drugs: Cross-Sectional Study of FDA Review Memos | Journal of General Internal Medicine | Sarah Tanveer et al.
(link.springer.com)
Less than half of serious adverse events analyses submitted to the FDA in 2022 as part of a successful new drug application followed the statistical preferences encouraged by the FDA. Seems like the sort of problem that should not exist anymore with AI.
Some interesting “myth busting” for the 2000s Irish housing bubble
An interesting perspective in which Terrence advocates for a shift in what the field considers to be work worthy of prestige. A new emphasis is needed to aid the community curation, digestion & communication of mathematical results.
Fu n gam e t o seeho w ba d s om e f onts a re
A thoughtful reflection on trust, expanding its scope beyond the world of agential beings, featuring defensive driving and Roscoe’s chicken & waffle house.
Sanitation, human rights, aging and other invisible scaffolding of NYC life explored through artist in residency programming
Repost this lynk